Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Freeze-dried Human Rabies Vaccine (Vero cell)
- Development stage
- Phase 3
- Lead developer
- AIM Vaccine Co.
- Modality
- Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
The Freeze-dried Human Rabies Vaccine (Vero cell) is an inactivated viral vaccine developed and marketed by AIM Vaccine Co., Ltd. (through its subsidiary AIM Honesty). Produced by cultivating the rabies virus in Vero cells followed by inactivation and lyophilization, the vaccine is designed to elicit neutralizing antibodies that prevent rabies virus infection. It is indicated for both pre-exposure prophylaxis in high-risk individuals (such as veterinarians and laboratory workers) and post-exposure prophylaxis following potential exposure to the virus through animal bites or scratches. The product has a significant market presence in China, maintaining a consistent record of quality control and batch release approval for over seventeen consecutive years.
- Other names
- Freeze-dried Human Rabies Vaccine (Vero cell)Human Rabies Vaccine (Vero cell)AIM Honesty Rabies Vaccine
Beyond the preview
Go deeper on Freeze-dried Human Rabies Vaccine (Vero cell).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Freeze-dried Human Rabies Vaccine (Vero cell).